AIP.NASDAQArteris, INC

Form 4: Arteris VP and General Counsel Reports Sales of Common Stock Under Tax and 10b5-1 Plans

Sentiment:

Insider Transaction Report


Paul L. Alpern, VP and General Counsel of Arteris, Inc., reported the sale of 6,488 shares of common stock in early July 2025, primarily to cover tax liabilities from restricted stock unit releases and pursuant to a pre-arranged 10b5-1 trading plan.

Summary

  • Paul L. Alpern, VP and General Counsel of Arteris, Inc. (AIP), reported transactions involving the sale of common stock.
  • On July 2, 2025, Alpern sold a total of 2,879 shares of common stock at a price of $8.9924 per share. These sales included 1,179 shares, 691 shares, and 1,009 shares.
  • These sales on July 2, 2025, were conducted to satisfy the reporting person's tax liability arising from the release of restricted stock units.
  • On July 3, 2025, an additional 3,609 shares of common stock were sold at a weighted average price of $9.2466 per share. The individual sale prices for these shares ranged from $9.14 to $9.38.
  • The transaction on July 3, 2025, was made pursuant to a Rule 10b5-1 trading plan, which was adopted by Alpern on May 8, 2024.
  • Following these reported transactions, Paul L. Alpern beneficially owns 76,547 shares of Arteris, Inc. common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider sales reduce ownership, the stated reasons (tax liability and pre-planned 10b5-1 sales) are routine and do not typically indicate negative sentiment about the company's prospects.

Positives

  • The sale of 3,609 shares was conducted under a pre-arranged 10b5-1 trading plan, indicating a structured and pre-determined transaction rather than an opportunistic sale based on immediate, non-public information.

Negatives

  • The transactions resulted in a reduction of Paul L. Alpern's direct beneficial ownership in Arteris, Inc. common stock by a total of 6,488 shares.

Future Outlook

This filing is a report of past insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

  • Shares were sold to satisfy the reporting person's tax liability arising as a result of the release of restricted stock units.
  • The transaction on July 3, 2025, was made pursuant to a 10b5-1 trading plan that was adopted by the reporting person on May 8, 2024.

Industry Context

This Form 4 filing details specific insider transactions and does not provide broader industry context or trends. Insider sales for tax purposes or under pre-arranged 10b5-1 plans are common occurrences across various industries.

Stakeholder Impact

  • Shareholders will observe a slight reduction in the direct beneficial ownership of a key executive, Paul L. Alpern, which is a common occurrence for tax planning and pre-scheduled trading.

Key Dates

DateDescription
05/08/2024Date the 10b5-1 trading plan was adopted by Paul L. Alpern.
07/02/2025Date of sale of 2,879 shares of common stock to satisfy tax liability from RSU release.
07/03/2025Date of sale of 3,609 shares of common stock pursuant to a 10b5-1 trading plan.
07/07/2025Date the Form 4 filing was signed.

Keywords

Arteris, AIP, Form 4, Insider Trading, Stock Sale, Paul Alpern, 10b5-1 Plan, Common Stock, Beneficial Ownership, Restricted Stock Units, Tax Liability

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.